Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion type Assertion NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_head.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion description "[However, treatment with the MEK1/2 inhibitors U0126, PD184352 or the novel clinical candidate AZD6244 (ARRY-142886) overcomes growth factor independence, causing CRC cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_provenance.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion evidence source_evidence_literature NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_provenance.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion SIO_000772 18806830 NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_provenance.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion wasDerivedFrom befree-20150227 NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_provenance.
- NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_assertion wasGeneratedBy ECO_0000203 NP645813.RAdEmpt8CXBYeBur0yrPrtFYDn7fwGawsLRNhQhy22VJE130_provenance.